GyroStim is more than breakthrough neurotechnology. It is a strategic investment in the clinical capabilities, competitive differentiation, growth, and long-term value of your practice.
By helping providers deliver exceptional outcomes while expanding the patients, services, and markets they can serve, GyroStim creates an opportunity to transform both patient care and practice performance.
-
Deliver Exceptional Patient Outcomes
-
Differentiate With FDA Breakthrough Technology
-
Expand Clinical Capabilities
-
Attract New Patients and Referral Sources
-
Excel in High-Growth Neurological Markets
-
Create New Revenue-Generating Programs
-
Increase Patient Engagement and Retention
-
Complement and Extend Existing Neurorehab Programs
-
Build a Reputation for Clinical Innovation and Excellence
-
Build a Stronger, More Valuable Practice
Providers & Clinics
Exceptional Outcomes Build Exceptional Practices.
x
x
X
x
x
x
x
Traditional Therapy: Neurological systems are typically trained sequentially and in relative isolation, limiting the degree of multisensory interaction.
GyroStim: Multiple neurological systems are engaged simultaneously through precisely controlled multisensory stimulation, delivering a level of integrated sensorimotor challenge difficult to achieve through conventional therapy alone.
x
x
FDA-Recognized Breakthrough Technology for Vestibular Dysfunction
GyroStim is “intended to assist in the treatment of balance disorders and vestibular dysfunction” and designated by the FDA as a Breakthrough Device, placing vestibular care and balance rehabilitation at the core of its regulatory distinction. In retrospective clinical analyses, GyroStim was associated with up to a fivefold faster rate of improvement than standard of care alone across multiple validated balance measures.
5X Faster Improvement → Greater Patient Satisfaction → More Referrals → Practice Growth
For providers, better outcomes can create value far beyond the treatment room. Faster improvement in vestibular function and balance can lead to greater patient satisfaction, stronger word-of-mouth, increased physician and professional referrals, and a growing reputation for delivering exceptional results. Combined with the differentiation of FDA-cleared, FDA Breakthrough Device-designated technology, GyroStim gives practices a powerful and highly marketable story of clinical innovation and better outcomes that can help attract new patients, strengthen referral relationships, expand clinical volume, and accelerate practice growth.
Based on clinical data provided by Kim Fox, DPT, Clinical Director & Founder, AVORA Health, Asheville, NC.
What leading clinicians want you to know about GyroStim:
"From day one our practice changed for the better and patients came from all over the world to receive treatment. The results we have seen with complex central vestibular disorders, post-concussion, and dysautonomia have led to many other providers referring to us."
--- Dr. Jeremy Schmoe
Minnetonka, MN
Owner Since 2018
3 GyroStim systems
“GyroStim technology has added depth to our treatment programs for patients suffering from vestibular complaints and disorders, sensorimotor challenges, PTSD, and developmental disorders. Our patients love the technology, but more importantly, they love the results."
--- Dr. Darcy Dane
Raleigh, NC
Owner Since 2022
1 GyroStim system
“Now that I have one, I can’t imagine ever not having a GyroStim in my practice.
The GyroStim is spectacular, we are getting amazing outcomes. It is the best decision we have ever made.”
--- Dr. Joe Schneider
Chadds Ford, PA
Owner Since 2020
1 GyroStim system
Proven Safe.
Proven Effective.
Proven Transformative.
GyroStim is ushering in a new era of precision neurotherapeutics. As the only FDA-cleared, Breakthrough Device-designated multimodal neurorehabilitation system, GyroStim delivers powerful, precisely controlled, progressively adaptive neurological therapy with a level of precision, consistency, repeatability, and treatment intensity that extends far beyond the capabilities of conventional rehabilitation alone.
By extending clinical capabilities through robotic automation, intelligent software, and precision neurotechnology, GyroStim empowers practices to improve clinical outcomes, differentiate themselves in an increasingly competitive marketplace, expand into high-growth specialties including concussion, longevity, and human performance, and establish themselves as leaders in the future of neurological rehabilitation.
The GyroStim Difference
Traditional Therapy: Delivers primarily manual, therapist-dependent, low-density exercises that typically train individual neurological systems sequentially and in isolation.
GyroStim: Delivers precisely controlled, repeatable, high-density multimodal neurorehabilitation that simultaneously engages multiple neurological systems through progressively adaptive multisensory stimulation.
Traditional Therapy: Therapeutic dose can be difficult to precisely quantify, control, and reproduce from session to session and is
often estimated and subject to variability from one therapist, and patient response to the next.
GyroStim: Therapeutic dose is precisely quantified, consistently delivered, and reliably reproduced enabling data-driven progression from run to run and session to session.
Traditional Therapy: Therapeutic intensity is often limited by patient tolerance, therapist fatigue, and the practical constraints of manually delivered treatment.
GyroStim: Computer-controlled automation enables precisely regulated, progressively adaptive, and consistently repeatable therapeutic intensity tailored to each patient's needs.
Traditional Therapy: Neurological systems are typically trained sequentially and in relative isolation, limiting the degree of multisensory interaction.
GyroStim: Simultaneous engagement of five interconnected neurological systems—vestibular, visual, motor, somatosensory, and cognitive—creates a synergistic neurological environment where each system challenges and reinforces the others, producing a multimodal effect far greater than the sum of its individual parts.
Traditional Therapy: Time-consuming, labor-intensive, and often limited in its ability to deliver meaningful economic returns.
GyroStim: FDA Breakthrough Device-designated for its potential to provide more effective treatment of balance disorders and vestibular dysfunction, offering the potential for significant reductions in fall risk and substantial return on investment.
Traditional Therapy: Many conventional rehabilitation approaches require mobility, endurance, and active participation beyond the abilities of individuals with severe physical or cognitive impairments.
GyroStim: Designed for all patients across the full spectrum of function, GyroStim's multi-axis rotational platform does the heavy lifting so even those with limited mobility and complex neurological challenges can have access to vital neurorehabilitation.
Traditional Therapy: Time-intensive, it can take months or longer to achieve meaningful clinical improvement.
GyroStim: Designed to accelerate recovery, clinical evidence demonstrates many times faster rate of improvement than traditional therapy.
Traditional Therapy: Safety and treatment consistency are influenced by physical demands, operator variability, and patient limitations.
GyroStim: Delivered within a precisely controlled environment engineered for safety, with millions of patient rotations and a perfect safety record since 2010.
Traditional Therapy: Difficult to scale with precision and consistency due to variability between therapists and treatment approaches.
GyroStim: Designed for precise replication and scalable deployment, enabling standardized, repeatable neurotherapeutics across providers, facilities, and healthcare systems.
Traditional Therapy: Established clinical approaches, but without the added credibility and distinction of advanced FDA-recognized medical technology.
GyroStim: FDA-cleared and FDA Breakthrough Device-designated, bringing exceptional regulatory credibility and advanced neurotechnology to neurological rehabilitation.
Proven safe.
Proven effective.
Proven transformative.
-
FDA-Cleared K220231: for the treatment of balance disorders and vestibular dysfunction—common and often debilitating neurological conditions associated with head injury, numerous neurological disorders, and age-related neurological decline.
-
Safe: Exceeds all regulatory requirements - zero injuries since clinical applications began in 2010.
-
Effective: Up to 8x faster rehabilitation rate for concussion recovery than conventional therapies alone.
-
Accessible: Unlike traditional therapies, GyroStim is accessible to a broader range of patients—including those with severe physical or cognitive disabilities.
-
Transformative: GyroStim has transformed tens of thousands of lives since 2010, advancing neurological recovery, human performance, and quality of life around the world.
